ArticleRSC advances2025
A calcium sulfate hemihydrate self-setting interface reinforced polycaprolactone porous composite scaffold.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mechanical insufficiency and slow degradation of polycaprolactone (PCL) implants have attracted widespread attention among researchers. Herein, a PCL scaffold with self-setting properties containing calcium sulfate hemihydrate (CSH) was prepared using a triply periodic minimal surfaces (TPMS) design and selective laser sintering (SLS) technology. The results showed that the strength of the scaffold containing 10 wt% CSH was increased by 45.5% compared to the PCL one. More importantly, its strength can be further increased to 1.7 times that of the PCL scaffold after self-setting in water. Mechanism analysis suggests that mechanical strengthening can be attributed to the pinning effect through the newly grown columnar crystals embedded with PCL molecular chains. In addition, the degradation rate of the composite scaffold was approximately 6.8 times higher than that of the PCL one. The study believes that the increase in degradation rate is due to a dual effect, specifically the increase in permeability and the catalytic degradation of PCL in the acidic environment. Encouragingly, the composite scaffold showed a good ability to induce hydroxyapatite formation. Therefore, the self-setting mechanically enhanced composite scaffold is expected to have potential application prospects in bone defect repair.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.